Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000586888 | SCV000525860 | benign | not provided | 2016-10-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000554272 | SCV000656037 | benign | Noonan syndrome 9 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586888 | SCV000698749 | benign | not provided | 2017-04-12 | criteria provided, single submitter | clinical testing | Variant summary: The SOS2 c.622G>A (p.Ala208Thr) variant causes a missense change involving the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 2245/121196 control chromosomes at a frequency of 0.0185237, which is approximately 7409 times the estimated maximal expected allele frequency of a pathogenic SOS2 variant (0.0000025), suggesting this variant is likely a benign polymorphism. In addition, one clinical diagnostic laboratory classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. |
ARUP Laboratories, |
RCV000554272 | SCV001159482 | benign | Noonan syndrome 9 | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813479 | SCV002060683 | benign | Noonan syndrome and Noonan-related syndrome | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365514 | SCV002658238 | benign | Cardiovascular phenotype | 2019-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000554272 | SCV002763124 | benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Ce |
RCV000586888 | SCV004134091 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | SOS2: BS1, BS2 |
Breakthrough Genomics, |
RCV000586888 | SCV005289551 | benign | not provided | criteria provided, single submitter | not provided |